Literature DB >> 19834965

Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells.

Dorota Pozarowska1, Piotr Pozarowski, Zbigniew Darzynkiewicz.   

Abstract

BACKGROUND: The long-term-treatment of glaucoma with topical medications is associated with side effects involving cornea damage. We examined the effect of glaucoma topical medications (bimatoprost, travoprost, latanoprost, timolol, betaxolol, dorzolamide, brinzolamide, brimonidine) on growth of cells of three human epithelial corneal lines.
METHODS: The cells were cultured in 8-chamber slides, treated with different concentrations of the medications, and fixed at 24, 48, and 72 h. Cell number on slides to estimate viability and growth curves, frequency of apoptosis (FLICA and caspase-3 activation probes), and proliferation (BrdU incorporation assay) were measured by laser scanning cytometry (LSC).
RESULTS: Depending on concentration all examined medications induced cell necrosis or apoptosis and suppressed proliferation. Significant variability in proliferation and apoptosis was observed within the same cultures depending on local cell density, with cells in high density areas being more resistant. The data indicate that commonly used topical medications exert cytostatic and cytotoxic effects in cultures of corneal cells and suggest that caution should be exercised in their use, particularly, when the corneal diseases are accompanied by cell proliferation and regeneration, in long-term-treatment.
CONCLUSIONS: The present approach of using LSC makes it possible to assess and compare cytostatic and cytotoxic effects of different topical medications on the respective target cells. (c) 2009 Clinical Cytometry Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19834965      PMCID: PMC3003611          DOI: 10.1002/cyto.b.20493

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  26 in total

1.  Laser scanning cytometry: principles and applications.

Authors:  Piotr Pozarowski; Elena Holden; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2006

Review 2.  The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.

Authors:  Richard W Yee
Journal:  Curr Opin Ophthalmol       Date:  2007-03       Impact factor: 3.761

3.  Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma.

Authors:  Paul J Harasymowycz; Demosthenes G Papamatheakis; Marguerite Ennis; Mary Brady; Keith D Gordon
Journal:  Cornea       Date:  2007-01       Impact factor: 2.651

4.  Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system.

Authors:  Richard W Yee; Evan G Norcom; Xinping C Zhao
Journal:  Adv Ther       Date:  2006 Jul-Aug       Impact factor: 3.845

5.  Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells.

Authors:  Kwou-Yeung Wu; Hwei-Zu Wang; Show-Jen Hong
Journal:  Kaohsiung J Med Sci       Date:  2007-03       Impact factor: 2.744

6.  In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.

Authors:  Christophe Baudouin; Luisa Riancho; Jean-Michel Warnet; Françoise Brignole
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

7.  Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.

Authors:  Malik Y Kahook; Robert J Noecker
Journal:  Cornea       Date:  2008-04       Impact factor: 2.651

8.  Effects of topical antiglaucoma medications on corneal epithelium as evaluated by gene expression patterns.

Authors:  Yuka Okada
Journal:  Cornea       Date:  2007-10       Impact factor: 2.651

9.  In vivo corneal epithelial permeability following treatment with prostaglandin analogs [correction of analoges] with or without benzalkonium chloride.

Authors:  Bernard McCarey; Henry Edelhauser
Journal:  J Ocul Pharmacol Ther       Date:  2007-10       Impact factor: 2.671

10.  Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines.

Authors:  E Brasnu; F Brignole-Baudouin; L Riancho; J-M Warnet; C Baudouin
Journal:  Mol Vis       Date:  2008-03-04       Impact factor: 2.367

View more
  7 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

Review 2.  Laser scanning cytometry: principles and applications-an update.

Authors:  Piotr Pozarowski; Elena Holden; Zbigniew Darzynkiewicz
Journal:  Methods Mol Biol       Date:  2013

3.  Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.

Authors:  Dorota Pozarowska
Journal:  Clin Ophthalmol       Date:  2010-10-21

4.  A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients.

Authors:  Stefano Ranno; Matteo Sacchi; Cinzia Brancato; Daniela Gilardi; Andrea Lembo; Paolo Nucci
Journal:  ScientificWorldJournal       Date:  2012-04-19

5.  Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog.

Authors:  Yoshie Shimizu; Shunsuke Nakakura; Makiko Nishiyama; Hitoshi Tabuchi; Yoshiaki Kiuchi
Journal:  Clin Ophthalmol       Date:  2015-03-11

Review 6.  A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Authors:  Xiaoyu Zhou; Xinyue Zhang; Dengming Zhou; Yang Zhao; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-08-09

Review 7.  Human corneal cell culture models for drug toxicity studies.

Authors:  Seppo Rönkkö; Kati-Sisko Vellonen; Kristiina Järvinen; Elisa Toropainen; Arto Urtti
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.